has buy call on with a target price of Rs 930. The current market price of Ipca Laboratories is Rs 873.85.
., incorporated in the year 1949, is a Mid Cap company (having a market cap of Rs 22172.48 Crore) operating in Pharmaceuticals sector.
Ipca Laboratories Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Operating Revenue, Export Incentives, Sale of services for the year ending 31-Mar-2022.
Financials
For the quarter ended 30-06-2022, the company reported a Consolidated Total Income of Rs 1607.85 Crore, up 23.34 % from last quarter Total Income of Rs 1303.64 Crore and up 1.33 % from last year same quarter Total Income of Rs 1586.81 Crore. Company reported net profit after tax of Rs 148.43 Crore in latest quarter.
Promoter/FII Holdings
Promoters held 46.29 per cent stake in the company as of 30-Jun-2022, while FIIs owned 10.61 per cent, DIIs 33.5 per cent.
., incorporated in the year 1949, is a Mid Cap company (having a market cap of Rs 22172.48 Crore) operating in Pharmaceuticals sector.
Ipca Laboratories Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Operating Revenue, Export Incentives, Sale of services for the year ending 31-Mar-2022.
Financials
For the quarter ended 30-06-2022, the company reported a Consolidated Total Income of Rs 1607.85 Crore, up 23.34 % from last quarter Total Income of Rs 1303.64 Crore and up 1.33 % from last year same quarter Total Income of Rs 1586.81 Crore. Company reported net profit after tax of Rs 148.43 Crore in latest quarter.
Promoter/FII Holdings
Promoters held 46.29 per cent stake in the company as of 30-Jun-2022, while FIIs owned 10.61 per cent, DIIs 33.5 per cent.
(Disclaimer: Recommendations given in this section or any reports attached herein are authored by an external party. Views expressed are that of the respective authors/entities. These do not represent the views of Economic Times (ET). ET does not guarantee, vouch for, endorse any of its contents and hereby disclaims all warranties, express or implied, relating to the same. Please consult your financial adviser and seek independent advice.
Read More News on
(What's moving Sensex and Nifty Track latest market news, stock tips and expert advice on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds.)
...moreDownload The Economic Times News App to get Daily Market Updates & Live Business News.
Pick the best stocks for yourself
Powered by